Aytu BioPharma stockholders elect all director nominees, ratify auditor, approve say-on-pay

AYTU BIOPHARMA, INC

All five incumbent directors reelected: Disbrow, Donofrio, Dockery, Jain, Liu with majority votes.
Grant Thornton LLP ratified as independent auditor for fiscal 2026: 5,783,905 for, 257,411 against.
Non-binding advisory vote on executive compensation approved: 3,193,511 for, 311,200 against.
Approximately 60% of outstanding shares (6,083,713) present or represented at meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.